Case Report: Pathologic complete response in a patient with simultaneous diagnoses of resectable NSCLC and myeloid neoplasm with PDGFRA rearrangement treated with concurrent neoadjuvant chemoimmunotherapy and imatinib: translating clinical trial data to real-world practice

病例报告：一例同时诊断为可切除非小细胞肺癌和伴有PDGFRA重排的髓系肿瘤的患者，接受新辅助化疗联合免疫疗法和伊马替尼治疗后达到病理完全缓解：将临床试验数据转化为真实世界实践